Abstract: Provided are a dual-junction thin film solar cell module, and preparation method thereof. The cell module is formed by multiple cell units connected in series, and each cell unit comprises a selectively grown substrate (105), a bottom cell (106), and a top cell (126). A front metal electrode layer (200) is provided on the top cell (126), and the selectively grown substrate (105) comprises a metal base (100), a patterned insulation layer (102), and an N-type microcrystalline germanium seed layer (104), the insulation layer (102) is formed on the metal base (100), and the N-type microcrystalline germanium seed layer (104) is in the pattern formed by the insulation layer (102). The bottom cell (106) is a polycrystalline germanium bottom cell layer, and the top cell (126) is a GaAs cell.

Abstract: This disclosure concerns compounds which are useful as inhibitors of protein kinase C (PKC) and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC. This disclosure also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

Abstract: The invention encompasses compounds having formula I or II and the compositions and methods using these compounds in the treatment of conditions in which inhibition of PKC and PKD is therapeutically useful.

Abstract: This disclosure concerns compounds which are useful as inhibitors of protein kinase C (PKC) and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC. This disclosure also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

Abstract: This disclosure concerns compounds which are useful as inhibitors of protein kinase C (PKC) and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC. This disclosure also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

Abstract: The invention encompasses compounds having formula I or II and the compositions and methods using these compounds in the treatment of conditions in which inhibition of PKC and PKD is therapeutically useful.